Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T
- PMID: 12952925
- PMCID: PMC182182
- DOI: 10.1172/JCI15967
Decreased energetics in murine hearts bearing the R92Q mutation in cardiac troponin T
Abstract
The thin filament protein cardiac troponin T (cTnT) is an important regulator of myofilament activation. Here we report a significant change in cardiac energetics in transgenic mice bearing the missense mutation R92Q within the tropomyosin-binding domain of cTnT, a mutation associated with a clinically severe form of familial hypertrophic cardiomyopathy. This functional domain of cTnT has recently been shown to be a crucial modulator of contractile function despite the fact that it does not directly interact with the ATP hydrolysis site in the myosin head. Simultaneous measurements of cardiac energetics using 31P NMR spectroscopy and contractile performance of the intact beating heart revealed both a decrease in the free energy of ATP hydrolysis available to support contractile work and a marked inability to increase contractile performance upon acute inotropic challenge in hearts from R92Q mice. These results show that alterations in thin filament protein structure and function can lead to significant defects in myocardial energetics and contractile reserve.
Figures



Comment in
-
Cardiac troponin T and familial hypertrophic cardiomyopathy: an energetic affair.J Clin Invest. 2003 Sep;112(5):652-4. doi: 10.1172/JCI19632. J Clin Invest. 2003. PMID: 12952912 Free PMC article.
Similar articles
-
Myosin-driven rescue of contractile reserve and energetics in mouse hearts bearing familial hypertrophic cardiomyopathy-associated mutant troponin T is mutation-specific.J Physiol. 2012 Nov 1;590(21):5371-88. doi: 10.1113/jphysiol.2012.234252. Epub 2012 Aug 20. J Physiol. 2012. PMID: 22907055 Free PMC article.
-
Cardiac troponin T mutations: correlation between the type of mutation and the nature of myofilament dysfunction in transgenic mice.J Physiol. 2001 Oct 15;536(Pt 2):583-92. doi: 10.1111/j.1469-7793.2001.0583c.xd. J Physiol. 2001. PMID: 11600691 Free PMC article.
-
R-92L and R-92W mutations in cardiac troponin T lead to distinct energetic phenotypes in intact mouse hearts.Biophys J. 2007 Sep 1;93(5):1834-44. doi: 10.1529/biophysj.107.107557. Epub 2007 May 25. Biophys J. 2007. PMID: 17526570 Free PMC article.
-
Hypertrophic cardiomyopathy:a paradigm for myocardial energy depletion.Trends Genet. 2003 May;19(5):263-8. doi: 10.1016/S0168-9525(03)00081-7. Trends Genet. 2003. PMID: 12711218 Review.
-
Molecular mechanisms regulating the myofilament response to Ca2+: implications of mutations causal for familial hypertrophic cardiomyopathy.Basic Res Cardiol. 1997;92 Suppl 1:63-74. doi: 10.1007/BF00794070. Basic Res Cardiol. 1997. PMID: 9202846 Review.
Cited by
-
Sarcomeric proteins and familial hypertrophic cardiomyopathy: linking mutations in structural proteins to complex cardiovascular phenotypes.Heart Fail Rev. 2005 Sep;10(3):237-48. doi: 10.1007/s10741-005-5253-5. Heart Fail Rev. 2005. PMID: 16416046 Review.
-
Moving beyond simple answers to complex disorders in sarcomeric cardiomyopathies: the role of integrated systems.Pflugers Arch. 2019 May;471(5):661-671. doi: 10.1007/s00424-019-02269-0. Epub 2019 Mar 8. Pflugers Arch. 2019. PMID: 30848350 Free PMC article. Review.
-
Increased Myocardial Oxygen Consumption Precedes Contractile Dysfunction in Hypertrophic Cardiomyopathy Caused by Pathogenic TNNT2 Gene Variants.J Am Heart Assoc. 2020 Apr 21;9(8):e015316. doi: 10.1161/JAHA.119.015316. Epub 2020 Apr 15. J Am Heart Assoc. 2020. PMID: 32290750 Free PMC article.
-
Mechano-energetic uncoupling in hypertrophic cardiomyopathy: Pathophysiological mechanisms and therapeutic opportunities.J Mol Cell Cardiol Plus. 2023 May 6;4:100036. doi: 10.1016/j.jmccpl.2023.100036. eCollection 2023 Jun. J Mol Cell Cardiol Plus. 2023. PMID: 39801694 Free PMC article. Review.
-
Mechanical and energetic properties of papillary muscle from ACTC E99K transgenic mouse models of hypertrophic cardiomyopathy.Am J Physiol Heart Circ Physiol. 2013 Jun 1;304(11):H1513-24. doi: 10.1152/ajpheart.00951.2012. Epub 2013 Apr 19. Am J Physiol Heart Circ Physiol. 2013. PMID: 23604709 Free PMC article.
References
-
- Maron BJ, Bonow RO, Cannon RO, 3rd, Leon MB, Epstein SE. Hypertrophic cardiomyopathy. Interrelations of clinical manifestations, pathophysiology, and therapy. N. Engl. J. Med. 1987;316:780–789. - PubMed
-
- Towbin JA. Molecular genetics of hypertrophic cardiomyopathy. Curr. Cardiol. Rep. 2000;2:134–140. - PubMed
-
- Tobacman LS, et al. The troponin tail domain promotes a conformational state of the thin filament that suppresses myosin activity. J. Biol. Chem. 2002;277:27636–27642. - PubMed
-
- Maytum R, Geeves MA, Lehrer SS. A modulatory role for the troponin T tail domain in thin filament regulation. J. Biol. Chem. 2002;277:29774–29780. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials